Evidence map›Paper›PMID 35583203›Full record

ReviewFuture medicinal chemistry2022

Sirtuin modulators: past, present, and future perspectives.

Francesco Fiorentino, Nicola Mautone, Martina Menna, Francesca D'Acunzo, Antonello Mai, Dante Rotili

Open access · greenAbstract readReview
In one paragraph

Review in Future medicinal chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. SIRT1, resveratrol and aging.Frontiers in genetics · 2024
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. SIRT4 in ageing.Biogerontology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Francesco FiorentinoDepartment of Drug Chemistry & Technologies, Sapienza University of Rome, P. le A. Moro 5, Rome, 00185, Italy.ORCID 0000-0003-3550-1860
Nicola MautoneDepartment of Drug Chemistry & Technologies, Sapienza University of Rome, P. le A. Moro 5, Rome, 00185, Italy.ORCID 0000-0002-2918-3184
Martina MennaDepartment of Drug Chemistry & Technologies, Sapienza University of Rome, P. le A. Moro 5, Rome, 00185, Italy.ORCID 0000-0001-5903-9135
Francesca D'AcunzoInstitute of Biological Systems (ISB), Italian National Research Council (CNR), Sezione Meccanismi di Reazione, c/o Department of Chemistry, Sapienza University of Rome, P. le A. Moro 5, Rome, 00185, Italy.ORCID 0000-0001-8024-2402
Antonello MaiDepartment of Drug Chemistry & Technologies, Sapienza University of Rome, P. le A. Moro 5, Rome, 00185, Italy.ORCID 0000-0001-9176-2382
Dante RotiliDepartment of Drug Chemistry & Technologies, Sapienza University of Rome, P. le A. Moro 5, Rome, 00185, Italy.ORCID 0000-0002-8428-8763
Sapienza University of Rome · ITIstituto Pasteur · ITNational Research Council · IT

Funding

Histone Lysine deMethylation: Structures, Inhibitions and MechanismsR01GM114306 · NIGMS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHENG, XIAODONG · 2015 to 2018
$1.2M
NIGMS NIH HHS R01 GM114306
6 · The paper itself

Abstract

Sirtuins are NAD

Indexed as

NeoplasmsSirtuinsAnimalsGene Expression RegulationMammalsProtein IsoformsProtein IsoformsSirtuinsagingcancerdrug discoveryepigeneticsmetabolismneurodegenerationprotein lysine deacylationsirtuin modulatorssirtuins

Identifiers

PMID35583203
PMCPMC9185222
OpenAlexW4280524928

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.